Background. Policies to decrease dropout during waiting time for liver transplantation (LT) are under debate. Methods. We evaluated the allocation system from 1996 to 2003, when recipients had priority related to Child-Pugh score and donors >60 years were mainly offered to recipients with hepatocellular carcinoma (HCC). The outcomes of 656 patients with chronic liver disease (142 HCC and 514 non-HCC) listed for LT were prospectively evaluated, considering recipient and donor features. Results. Transplantation and dropout rates were similar between HCC and non-HCC patients: 64.1% vs. 70.6% and 26% vs. 22.6%. Multivariate analysis showed the probability of being transplanted within 3 months was related to Child-Pugh score >10 and to HCC...
Tumor progression before liver transplantation (OLT) is the main cause of dropout from the waiting l...
UnlabelledThe current system granting liver transplant candidates with hepatocellular carcinoma (HCC...
Aim: Liver transplantation (LT) for hepatocellular carcinoma (HCC)beyond the Milan criteria is still...
The best prioritization of patients with hepatocellular carcinoma (HCC) waiting for liver transplant...
It has been shown that patients with hepatocellular carcinoma (HCC) meeting the United Network for O...
Given the increasing incidence of hepatocellular carcinoma (HCC) and regional variation in liver tra...
The best prioritization of patients with hepatocellular carcinoma (HCC) waiting for liver transplant...
Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation...
Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation...
Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation...
In some countries where the Model for End-Stage Liver Disease (MELD) score is used for graft allocat...
We retrospectively evaluated the impact of our strategy for patients with hepatocellular carcinoma (...
The efficacy of the Meld system to allocate livers has never been investigated in European centers. ...
BACKGROUND/AIMS: Patients with hepatocellular carcinoma on the waiting list for liver transplantatio...
Living donor liver transplantation (LDLT) is an attractive option to decrease waitlist dropout, part...
Tumor progression before liver transplantation (OLT) is the main cause of dropout from the waiting l...
UnlabelledThe current system granting liver transplant candidates with hepatocellular carcinoma (HCC...
Aim: Liver transplantation (LT) for hepatocellular carcinoma (HCC)beyond the Milan criteria is still...
The best prioritization of patients with hepatocellular carcinoma (HCC) waiting for liver transplant...
It has been shown that patients with hepatocellular carcinoma (HCC) meeting the United Network for O...
Given the increasing incidence of hepatocellular carcinoma (HCC) and regional variation in liver tra...
The best prioritization of patients with hepatocellular carcinoma (HCC) waiting for liver transplant...
Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation...
Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation...
Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation...
In some countries where the Model for End-Stage Liver Disease (MELD) score is used for graft allocat...
We retrospectively evaluated the impact of our strategy for patients with hepatocellular carcinoma (...
The efficacy of the Meld system to allocate livers has never been investigated in European centers. ...
BACKGROUND/AIMS: Patients with hepatocellular carcinoma on the waiting list for liver transplantatio...
Living donor liver transplantation (LDLT) is an attractive option to decrease waitlist dropout, part...
Tumor progression before liver transplantation (OLT) is the main cause of dropout from the waiting l...
UnlabelledThe current system granting liver transplant candidates with hepatocellular carcinoma (HCC...
Aim: Liver transplantation (LT) for hepatocellular carcinoma (HCC)beyond the Milan criteria is still...